Filter Results:
(75)
Show Results For
- All HBS Web (125)
- Faculty Publications (9)
Show Results For
- All HBS Web (125)
- Faculty Publications (9)
Sort by
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and... View Details
Keywords: Dina Gerdeman
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
- 21 Oct 2015
- Research & Ideas
How to Predict if a New Business Idea is Any Good
industry like drug development, it’s not like you can just switch from one disease to another disease,” she says. While R&D-intensive ventures can shift the application of their underlying technology, Shu continues, the fact they are... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
organization among enterprises specializing in overseas ventures, they did not become the dominant form of large enterprises within British economy itself. Business groups organized under the holding company such as Calico Printers'... View Details
Keywords: Sean Silverthorne
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
Tella, and Lucas Llach Abstract—This article is an introduction to the special collection on Argentine Exceptionalism. First, we discuss why the case of Argentina is generally regarded as exceptional: the country was among the richest in... View Details
Keywords: Sean Silverthorne
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
direct special attention to it." Similarly, Daguerre, who invented photography, made his breakthrough when he put an exposed plate into a cabinet in which a thermometer had earlier shattered; mercury vapors from the broken... View Details
Keywords: by Sarah Jane Gilbert
- 27 Feb 2019
- Research & Ideas
The Hidden Cost of a Product Recall
Evidence from Medical Device Firms, released in January. Bigger recalls, bigger reactions Using 13 years of US Food and Drug Administration data and a novel set of competitor classification algorithms, the team created a detailed history... View Details
- 12 Dec 2005
- Research & Ideas
Using the Law to Strategic Advantage
create value and manage risk. Q: Most managers don't have law degrees, so who do they turn to get the legal background they will need to work with legal staff on the issues you identify? Will they need special training? A: I like to think... View Details
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say there are two big issues with... View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
solutions. Indeed, it was outsiders—those with expertise at the periphery of a problem's field—who were most likely to find answers and do so quickly. People often think about open source as a special case, as if such openness can only... View Details
Keywords: by Martha Lagace
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
for fifteen to twenty years, special intuition and judgment are required," he observes. "Compared with operations, marketing, and strategy, we don't really know as much about how to manage research or value it, especially when... View Details
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010... View Details
Keywords: Sean Silverthorne
- 12 Oct 2006
- First Look
First Look: October 12, 2006
prescriptions for companies, investors, and policymakers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character... View Details
Keywords: Sean Silverthorne